Citizen in a RepublicNH Bill Briefing
← All bills

SB 256 · 2026 · Senate · Health and Human Services Committee

Safety rules for clinician-administered drugs

AI-generated

(New Title) establishing safety and care requirements for clinician-administered drugs.

Establishes safety and procedural requirements governing the administration of clinician-administered drugs.AI-generated

Status

Referred to interim study (House) · May 14, 2026
  1. ✓Introduced
  2. ✓Senate
  3. ✕House
  4. Governor
  5. Law

Analysis

This bill establishes certain safety and procedural requirements for clinician-administered drugs.

From the bill's official ANALYSIS section.

In the bill's words

Quoted verbatim from the bill as amended by the Senate. Passages chosen from the operative text.Computed by this site

“In this subdivision, "clinician-administered drug" means an outpatient prescription drug, other than a vaccine, that:”
RSA 420-J:27
“No health insurer or pharmacy benefit manager shall mandate that a clinician-administered drug be dispensed by a pharmacy selected by the insurer or PBM and delivered to a provider for administration ("white bagging"), unless:”
RSA 420-J:28
“No health insurer or pharmacy benefit manager shall mandate that a pharmacy dispense a clinician-administered drug to a patient for transport to a health care provider for administration ("brown bagging"), unless:”
RSA 420-J:28

Official record

Bill page — docket & status

gc.nh.gov · the authoritative source

Sponsors

Sen. Tim McGoughRPrime
  • Sen. Bill GannonRChair· Judiciary
  • Sen. David RochefortRChair· Health and Human Services
  • Rep. John PotucekRVice Chair· Commerce and Consumer Affairs

Also: Rep. Julie MilesR

Public testimony

3 signed in online

67% support33% oppose0% neutral

Read the testimony · as of Aug 12, 2026

Votes

yeanay
Starting text: Bill as introduced
  • Mar 6, 2025SenateCommittee report: Rereferred to Committee5–0
    Overall
    100% yea
  • Mar 6, 2025SenateVoice voteRereferred to Committeeadopted
  • Jan 7, 2026SenateCommittee reportCommittee report: Ought to Pass with Amendment # 2025-3029s5–0
    Overall
    100% yea
  • Jan 7, 2026SenateVoice voteCommittee amendment 2025-3029sadopted
  • Jan 7, 2026SenateVoice voteOught to Pass with Amendment #2025-3029sadopted
    Resulting text: Bill as amended by the Senate
  • Feb 19, 2026HouseVoice voteVacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt)adopted
  • Apr 29, 2026HouseCommittee report· consent calendar: Refer for Interim Study15–0
    Overall
    100% yea
  • May 14, 2026HouseVoice voteRefer for Interim Studyadopted

Hearings and debates

  • Feb 12, 2025Public hearingSenate Health and Human Services16:28–17:361m 8slocated in the stream transcriptHearing
  • Mar 6, 2025Floor debateSenate floorWatchnot located in the transcript — opens the full streamCommittee Report: Rereferred to Committee; Rereferred to Committee — adopted, voice vote
  • Jan 7, 2026Floor debateSenate floorWatchnot located in the transcript — opens the full streamCommittee Report: Ought to Pass with Amendment # 2025-3029s; Ought to Pass with Amendment #2025-3029s — adopted, voice vote; Committee Amendment # 2025-3029s — adopted, voice vote
  • Feb 19, 2026Floor debateHouse floorWatchnot located in the transcript — opens the full streamIntroduced (in recess); Vacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt) — adopted, voice vote
  • Apr 7, 2026Public hearingHouse Commerce and Consumer Affairs5:59:55–6:02:332m 38slocated in the stream transcriptPublic Hearing
  • Apr 8, 2026Public hearingHouse Commerce and Consumer AffairsWatchnot located in the transcript — opens the full streamSubcommittee Work Session
  • Apr 22, 2026Public hearingHouse Commerce and Consumer AffairsWatchnot located in the transcript — opens the full streamSubcommittee Work Session
  • Apr 29, 2026Public hearingHouse Commerce and Consumer Affairs5:15–6:221m 7slocated in the stream transcriptCommittee Report: Refer for Interim Study; Executive Session
  • May 14, 2026Floor debateHouse floorWatchnot located in the transcript — opens the full streamRefer for Interim Study — adopted, voice vote

Timestamps locate where this bill is taken up in the chamber's YouTube stream.

Legislative history

  1. Jan 9, 2025SenIntroduced 01/09/2025 and Referred to Health and Human Services; SJ 3
  2. Feb 12, 2025SenHearing: 02/12/2025, Room 101, LOB, 09:15 am; SC 9
  3. Mar 6, 2025Sen: Rereferred to Committee, 03/06/2025; Vote 5-0; CC; SC 11
  4. Mar 6, 2025SenRereferred to Committee, MA, VV; 03/06/2025; SJ 6
  5. Jan 7, 2026Sen: Ought to Pass with Amendment # 2025-3029s, 01/07/2026; Vote 5-0; CC; SC 46
  6. Jan 7, 2026SenCommittee Amendment # 2025-3029s, AA, VV; 01/07/2026; SJ 1
  7. Jan 7, 2026SenOught to Pass with Amendment #2025-3029s, MA, VV; OT3rdg; 01/07/2026; SJ 1
  8. Feb 19, 2026HouseIntroduced (in recess of) 02/19/2026 and referred to Health, Human Services and Elderly Affairs HJ 5 P. 124
  9. Feb 19, 2026HouseVacated and Referred to Commerce and Consumer Affairs (Rep. Kofalt): MA VV (in recess of) 02/19/2026 HJ 5 P. 127
  10. Apr 7, 2026HousePublic Hearing: 04/07/2026 02:15 pm GP 159
  11. Apr 8, 2026HouseSubcommittee Work Session: 04/08/2026 10:00 am GP 229
  12. Apr 22, 2026HouseSubcommittee Work Session: 04/22/2026 10:00 am GP 229
  13. Apr 29, 2026HouseExecutive Session: 04/29/2026 10:00 am GP 229
  14. Apr 29, 2026House: Refer for Interim Study 04/29/2026 (Vote 15-0; CC) HC 19 P. 6
  15. May 14, 2026HouseRefer for Interim Study: MA VV 05/14/2026 HJ 13 P. 2

Coverage

No reporting linked yet.

Documents (PDF)

Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.